Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-02-19 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2016年度第一次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and procedures of a 2016 first extraordinary general meeting (临时股东大会) of a company. It details the convening, attendance, and voting procedures of the shareholders' meeting and concludes on the legality and validity of the meeting and its resolutions. It does not contain financial statements or financial performance data, nor is it an announcement of voting results or a proxy solicitation. It is a legal opinion related to a shareholders' meeting, which fits best under Legal Proceedings Report (LTR) as it involves legal validation of corporate governance actions rather than a direct management or board announcement or voting results declaration. The document length is short and focused on legal opinion, not a full report or announcement of results.
2016-02-19 Chinese
关于召开2016年第一次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2016 first extraordinary general meeting (临时股东大会) of 紫光古汉集团股份有限公司. It includes information on meeting time, voting methods (onsite and online), agenda items for shareholder approval, voting procedures, and proxy authorization forms. The content focuses on informing shareholders about the meeting logistics and agenda, including proposals related to non-public stock issuance, board elections, and amendments to company articles. There are no financial statements or detailed financial performance data present. The document is not a report of voting results but a notice and instructions for the upcoming shareholder meeting. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or for the Annual or Extraordinary General Meeting, including meeting notices and agendas.
2016-02-16 Chinese
在清华控股集团财务有限公司办理存贷款业务的风险处置预案
Regulatory Filings Classification · 95% confidence The document is a detailed risk management plan specifically addressing the handling of deposit and loan risks related to a financial company affiliated with the issuer. It includes organizational structure, responsibilities, risk reporting and disclosure, risk handling procedures, and follow-up measures. The document is formal, approved by the board, and references compliance with laws and disclosure requirements. It does not contain financial statements, earnings data, or audit results. It is not a report of financial results or an announcement of voting or capital changes. It is a regulatory compliance and risk management disclosure document. Given the content and length (3504 characters), it is not a report publication announcement but a formal regulatory filing related to risk management and compliance. Therefore, the best fitting category is Regulatory Filings (RNS).
2016-02-01 Chinese
独立董事候选人声明（傅翔燕）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of 紫光古汉集团股份有限公司 (Unisplendour Ancient Han Group Co., Ltd.). It contains statements about the candidate's qualifications, independence, compliance with regulatory requirements, and legal responsibilities. There are no financial statements, earnings data, or report summaries. The content is focused on the candidate's eligibility and compliance with rules for board membership, which aligns with announcements related to board or management information. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and contains substantive content, not just a brief announcement or certification, so it is not Regulatory Filings (RNS).
2016-02-01 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors of 紫光古汉集团股份有限公司 nominating a candidate for the position of independent director. It details the qualifications, compliance with legal and regulatory requirements, and independence criteria of the nominee. There is no financial data, no discussion of financial results, no mention of shareholder voting results, no mention of a meeting agenda or presentation, and no indication of a report publication or regulatory filing. The content is focused on board/management information specifically related to the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG).
2016-02-01 Chinese
第七届监事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions from the company's seventh supervisory board interim meeting. It discusses the approval and voting results on various proposals related to a non-public stock issuance plan, including adjustments to the validity period, feasibility analysis reports, and commitments by controlling shareholders and management. The document does not contain financial statements or detailed financial data but rather reports on meeting decisions and procedural matters. It is a formal announcement of board/management decisions rather than a full report or financial disclosure. Therefore, it fits best under Board/Management Information (MANG). The document length is short (2326 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2016-02-01 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.